Do you have a kidney transplant? Have you been diagnosed with recurrent Immunoglobulin A nephropathy (IgAN) or Focal Segmental Glomerulosclerosis (FSGS)? If so, this study may be of interest to you.

This study will use prenatal and postpartum interviews to understand people's birth expectations and desires before they give birth and how their experience matches up to their actual experience. I am interested in how expectations influence how people navigate their prenatal care and how this influences the birth experience. This study will take place in the Appalachian region. Participants will also have the option to provide a hair sample and a urine sample from their infant at 3 months if they wish to look at how these experiences affect stress hormones.

Do you exercise regularly? Are you between 18-35 years old? If so, you may be eligible to participate in a research study examining how the brain, eyes, and heart work together to maintain balance. Compensation provided.

This research study (IRB # 24-3153) involves completing an attention task on the computer with an EEG cap on your head. The attention task itself will take 50 minutes. The whole study (questionnaires, EEG setup, and study conclusion) will take two hours. This study aims to explore aspects of attention and to understand what happens in the brain when attention stays on something. Participants who have completed the study will earn $20 for their participation.

Are you a nurse in Saudi Arabia? We want to hear from you! Join our UNC study to share your thoughts on using genetics in nursing. Your feedback will help shape better nursing education and support your daily work.

Do you suffer from migraines? Are you interested in helping with migraine research?

The purpose of this immunotherapy study is to compare two different chemotherapy treatments administered before breast cancer surgery to see which has the better outcome.

Do you have a blood cancer or have received a stem cell transplant and have been diagnosed with a respiratory infection? If so, you might be eligible to take part in a study to see if an experimental treatment is effective at reducing the severity of the respiratory infection.

Do you have Acute Myeloid Leukemia (AML) and want to try a new study drug that might help treat your cancer?

An important goal of this study is to evaluate the length of time cancer is not growing or spreading in participants when treated with zanzalintinib compared to everolimus. In addition, this study will also evaluate if zanzalintinib can shrink tumors and help participants live longer as compared to everolimus. This information will help researchers learn if zanzalintinib can be used to treat neuroendocrine cancer.